|本期目录/Table of Contents|

[1]刘玉林,臧玉琴,王颖梅,等.基于生物信息学分析筛选宫颈癌进展中的关键基因[J].天津医科大学学报,2022,28(01):8-14.
 LIU Yu-lin,ZANG Yu-qin,WANG Ying-mei,et al.Identification of key genes in cervical cancer progression by integrated bioinformatics analysis[J].Journal of Tianjin Medical University,2022,28(01):8-14.
点击复制

基于生物信息学分析筛选宫颈癌进展中的关键基因(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
28卷
期数:
2022年01期
页码:
8-14
栏目:
生物信息学专题
出版日期:
2022-01-20

文章信息/Info

Title:
Identification of key genes in cervical cancer progression by integrated bioinformatics analysis
文章编号:
1006-8147(2022)01-0008-07
作者:
刘玉林臧玉琴王颖梅薛凤霞
(天津医科大学总医院妇产科;天津市女性生殖健康与优生重点实验室,天津 300052)
Author(s):
LIU Yu-linZANG Yu-qinWANG Ying-meiXUE Feng-xia
(Department of Gynecology and Obstetrics,The General Hospital,Tianjin Medical University;Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin 300052,China )
关键词:
宫颈癌生物信息学分析差异表达基因差异表达miRNA蛋白质-蛋白质相互作用网络miRNA-靶基因调控网络
Keywords:
cervical cancer bioinformatics analysisdifferentially expressed gene differentially expressed miRNA protein-protein interaction network miRNA-target regulatory network
分类号:
R737.33
DOI:
-
文献标志码:
A
摘要:
目的:通过生物信息学分析的方法,筛选宫颈癌进展中的关键基因,寻找潜在的分子标志物和治疗靶点。方法:在GEO(Gene Expression Omnibus)数据库中检索宫颈癌进展相关的mRNA和miRNA基因芯片数据,借助GEO2R分析差异表达基因(DEG)和差异表达miRNA(DEM),进行富集分析以及构建蛋白质-蛋白质相互作用(PPI)网络和miRNA-靶基因调控网络。结果:共筛选出250个DEG和166个DEM,并构建出由123个节点(node)和283项互相作用(edge)构成的PPI网络以及由66个节点和137个相互作用构成的miRNA-靶基因调控网络。经分析,ATAD2、SMC4和POLQ基因不仅是筛选出的表达上调的DEG,而且是PPI网络中枢纽蛋白的编码基因,并在miRNA-靶基因调控网络中同时受DEM—miR-20A、miR-20B、miR-106B和miR-17-5P的调控。结论:ATAD2、SMC4和POLQ基因可能在宫颈癌进展过程中发挥着重要作用。
Abstract:
Objective: To identify the key genes in cervical cancer progression by integrated bioinformatics analysis to search for potential biomarkers and therapeutic targets. Methods:The mRNA and miRNA microarray datasets related to the progression of cervical cancer were searched on the GEO(the Gene Expression Omnibus) database and differentially expressed gene(DEG) and differentially expressedmiRNA (DEM) were analyzed by GEO2R. Then, the functional enrichment analyses, protein-protein interaction(PPI) network and miRNA-target regulatory network construction were conducted. Results:Totally, 250 DEGs and 166 DEMs in the progression of cervical cancer were screened out,and a PPI network composed of 123 nodes and 283 edges and a miRNA-target regulatory network composed of 66 nodes and 137 edges were constructed. Based on a series of analyses, the genes ATAD2, SMC4 and POLQ were not only identified as the overexpressed DEGs, but also the coding genes of hub proteins in the PPI network and regulated by the DEMs,miR-20A,miR-20B,miR-106B and miR-17-5P in the miRNA-target gene regulatory network. Conclusion: ATAD2, SMC4 and POLQ genes may play important roles in the progression of cervical cancer.

参考文献/References:

[1] COHEN P A,JHINGRAN A,OAKNIN A,et al. Cervical cancer[J].Lancet,2019,393(10167):169-182.
[2] YI Y,LIU Y,WU W,et al. Reconstruction and analysis of circRNA miRNA mRNA network in the pathology of cervical cancer[J]. Oncol Rep,2019,41(4):2209-2225.
[3] ZHENG L,LI T,ZHANG Y,et al. Oncogene ATAD2 promotes cell proliferation,invasion and migration in cervical cancer[J]. Oncol Rep,2015,33(5):2337-2344.
[4] THADANI R,KAMENZ J,HEEGER S,et al. Cell-cycle regulation of dynamic chromosome association of the condensin complex[J].Cell Rep,2018,23(8):2308-2317.
[5] PALOU R,DHANARAMAN T,MARRAKCHI R,et al. Condensin ATPase motifs contribute differentially to the maintenance of chromosome morphology and genome stability[J]. PLoS Biol,2018,16(6):e2003980.
[6] HUANG K,JIA J,WU C,et al. Ribosomal RNA gene transcription mediated by the master genome regulator protein CCCTC-binding factor (CTCF) is negatively regulated by the condensin complex[J]. J Biol Chem,2013,288(36):26067-26077.
[7] ZHAO SG,EVANS JR,KOTHARI V,et al. The landscape of prognostic outlier genes in high-risk prostate cancer[J]. Clin Cancer Res,2016,22(7):1777-1786.
[8] WANG Z,SONG Y,LI S,et al. DNA polymerase theta(POLQ) is important for repair of DNA double-strand breaks caused by fork collapse[J]. J Biol Chem,2019,294(11):3909-3919.
[9] HONEGGER A,SCHILLING D,BASTIAN S,et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells[J]. PLoS Pathog,2015,1(3):e1004712.
[10] LIU X. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells[J].Biomed Pharmacother,2018,102:996-1002.
[11] ZHENG Z M,WANG X. Regulation of cellular miRNA expression by human papillomaviruses[J]. Biochim Biophys Acta,2011,1809(11/12):668-677.
[12] CHENG Y,GUO Y,ZHANG Y,et al. MicroRNA-106b is involved in transforming growth factor beta1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma[J]. J Exp Clin Cancer Res,2016,35:11.
[13] LI M Y,HU X X. Meta-analysis of microRNA expression profiling studies in human cervical cancer[J]. Med Oncol,2015,32(6):510.
[14] MA D,ZHANG Y Y,GUO Y L,et al. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer[J]. Chin Med J(Engl),2012,125(23):4270-4276
[15] KANG H W,WANG F,WEI Q,et al. miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells[J].FEBS Lett,2012,586(6):897-904.
[16] XIONG Y,SUN F,DONG P,et al. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling[J]. J Exp Clin Cancer Res,2017,36(1):48.
[17] ZHAO S,YAO D,CHEN J,et al. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo[J]. PLoS One,2015, 10(3):e0120905.
[18] ZHOU Q,DONG J,LUO R,et al. MicroRNA-20a regulates cell proliferation,apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer[J]. Eur J Pharmacol,2019,844:102-109.
[19] ZHU S Y,WU Q Y,ZHANG C X,et al. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1[J]. Biochem Biophys Res Commun,2018,505(1):309-316.
[20] CAI N,HU L,XIE Y,et al. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-beta receptor 2[J]. Eur Rev Med Pharmacol Sci,2018,22(7):1899-1906.

相似文献/References:

[1]李晶晶,赵卫东,王德华.72例宫颈癌术后并发症及卵巢功能分析[J].天津医科大学学报,2014,20(01):63.
[2]崔丽阳,岳天孚.高危型HPV持续感染的影响因素探讨[J].天津医科大学学报,2014,20(03):209.
 CUI Li-yang,YUE Tian-fu.Investigation on factors for persistent high-risk human papilloma virus infection[J].Journal of Tianjin Medical University,2014,20(01):209.
[3]孙 艳,齐 政,王德华,等.miR-186通过靶定CEA抑制宫颈癌细胞转移[J].天津医科大学学报,2016,22(04):288.
 SUN Yan,QI Zheng,WANG De-hua,et al.miR-186 inhibits cervical cancer migration by targetting CEA[J].Journal of Tianjin Medical University,2016,22(01):288.
[4]李 娜,李洪林,尹利荣.HPV E6/E7 mRNA与YAP在宫颈癌中的表达与相关性研究[J].天津医科大学学报,2018,24(04):307.
 LI Na,LI Hong-lin,YIN Li-rong.HPV E6/E7 mRNA and YAP expression and their correlation in cervical carcinoma[J].Journal of Tianjin Medical University,2018,24(01):307.
[5]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(04):360.
[6]陈 辉,樊茹佳,丁继侠.宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义[J].天津医科大学学报,2019,25(05):510.
 CHEN Hui,FAN Ru-jia,DING Ji-xia.Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues[J].Journal of Tianjin Medical University,2019,25(01):510.
[7]闫晓芳,谢 虹,汤 华.miR-3685通过靶向CTTN抑制宫颈癌细胞的迁移、侵袭及生长[J].天津医科大学学报,2020,26(01):8.
 YAN Xiao-fang,XIE Hong,TANG Hua.miR-3685 inhibits migration, invasion and growth of cervical cancer cells by targeting CTTN[J].Journal of Tianjin Medical University,2020,26(01):8.
[8]白丽丽,汤华.TNF-α诱导的circMAN1A2促进宫颈癌细胞的迁移、侵袭和增殖[J].天津医科大学学报,2020,26(02):103.
 BAI Li-li,TANG Hua.TNF-α-induced circMAN1A2 promotes migration, invasion and proliferation of cervical cancer cells[J].Journal of Tianjin Medical University,2020,26(01):103.
[9]赵敬,杨金豪,张文帆,等.2009—2020年中国女性生殖道支原体、衣原体和人乳头瘤病毒感染与宫颈癌发生相关性的Meta分析[J].天津医科大学学报,2021,27(04):396.
 ZHAO Jing,YANG Jin-hao,ZHANG Wen-fan,et al.A meta-analysis of association between Mycoplasma,Chlamydia infection and Human papillomavirus infection in female genital tract and cervical cancer in China from 2009 to 2020[J].Journal of Tianjin Medical University,2021,27(01):396.
[10]赵敬,杨金豪 综述,常艳敏,等.中国宫颈癌DNA甲基化标志物的研究进展[J].天津医科大学学报,2021,27(05):545.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金(81972448);天津市科委基金(20JCZDJC00330)
作者简介 刘玉林(1993-),女,硕士在读,研究方向:子宫内膜癌的基础与临床研究;通信作者:薛凤霞,E-mail:fengxiaxue1962@tmu.edu.cn。
更新日期/Last Update: 2022-01-20